|
Article Cited by others ORIGINAL ARTICLE
A randomized trial comparing low dose (40 or 80 mg) with standard dose (120 mg) of bacillus Calmette-Guerin for superficial bladder cancer
Vijjan Vivek, Mandhani Anil, Kapoor Rakesh, Dubey Deepak, Srivastava Aneesh, Ansari M S, Singh Pratipal, Kumar Anant
Year : 2006| Volume: 22| Issue : 4 | Page no: 317-321 | This article has been cited by | | 1 |
Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials |
|
| | Se Young Choi, Moon Soo Ha, Jung Hoon Kim, Byung Hoon Chi, Jin Wook Kim, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung | | | Investigative and Clinical Urology. 2022; 63 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule |
|
| | Kanuj Malik, Anand Raja, Lalgudi Subramaniam Ravishankar, Kathiresan Narayanaswamy, Venkatraman Radhakrishnan, Tenali Gnana Sagar | | | Indian Journal of Surgical Oncology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow) |
|
| | Yuvaraja B. Thyavihally, Preetham Dev, Santosh Waigankar, Abhinav Pednekar, Nevitha Athikari, Abhijit Raut, Archan Khandekar, Naresh Badlani, Ashishkumar Asari | | | Asian Journal of Urology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
XRCC1 codon 399 mutant allele: A risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy |
|
| | Mittal, R.D., Singh, R., Manchanda, P.K., Ahirwar, D., Gangwar, R., Kesarwani, P., Mandhani, A. | | | Cancer Biology and Therapy. 2008; 7(5): 647-652 | | | [Pubmed] [Google Scholar] | | | 5 |
Bacillus Calmette-Guerin in the management of superficial bladder cancer |
|
| | Kapoor, R., Vijjan, V., Singh, P. | | | Indian Journal of Urology. 2008; 24(1): 72-76 | | | [Pubmed] [Google Scholar] | | | 6 |
The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma |
|
| | Agrawal, M.S. and Agrawal, M. and Bansal, S. and Agarwal, M. and Lavania, P. and Goyal, J. | | | Urology. 2007; 70(6): 1075-1078 | | | [Pubmed] [Google Scholar] | | | 7 |
The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma |
|
| | Madhu S. Agrawal,Moneet Agrawal,Sumit Bansal,Mayank Agarwal,Prashant Lavania,Jitendra Goyal | | | Urology. 2007; 70(6): 1075 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|
